BDX
Becton, Dickinson and Company
Is BDX Halal?
Medical devices, diagnostics and biosciences instruments are generally permissible at the activity level, but the current asset-based financial screen fails because debt is 34.00% of assets.
What You Should Know
Becton, Dickinson and Company (BD) makes medical devices, diagnostics, medication-management systems, specimen-collection products, laboratory instruments and interventional products through its Medical, Life Sciences and Interventional segments. The March 31, 2026 Form 10-Q reports $50,832 million of total assets, $17,279 million of interest-bearing debt, $813 million of cash and equivalents, $3 million of short-term investments and $2,205 million of net trade receivables. Those inputs produce debt/assets of 34.00%, cash plus short-term investments/assets of 1.61%, receivables plus cash/assets of 5.94%, and disclosed interest income/revenue of 0.14% for the six-month period. The examined FTSE Yasaar, MSCI and Malaysia asset-ratio calculations fail on debt; market-cap methods are not calculated without a licensed historical series. Healthcare-equipment manufacturing is generally permissible at the activity level, but no universal prohibited-revenue numerator is disclosed. Product-liability accruals, the Waters/SpinCo separation, downstream customer use and access and safety questions remain qualitative diligence topics.
⚠️ Concerns
- •Current debt is 34.00% of total assets, just above the examined 33% asset-based limits; the screen is not a market-cap calculation
- •BD discloses $13 million of interest income for the six-month period, but no scholar-approved fixed purification percentage
- •The filing reports approximately $1.7 billion of accruals for product-liability and certain legal matters at March 31, 2026
- •The February 2026 Waters/SpinCo separation and discontinued operations can change the reported business perimeter
- •Medical-device safety, access, clinical-research and customer-use questions warrant investor-level ethical review
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.
17,279 / 50,832
816 / 50,832
3,018 / 50,832
13 / 9,200
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, just above the examined 33.333% FTSE asset limit. Liquidity is 1.61%, receivables plus cash are 5.94%, and disclosed interest income is 0.14%; debt is decisive.
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, above the examined MSCI total-assets limit, while liquidity is 1.61% and receivables plus cash are 5.94%. This is a calculation against the named method, not an index-membership claim.
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, above the examined 33% Malaysia SAC financial limit; liquidity is 1.61%. This is a calculation against SAC ratios, not an official classification of a U.S.-listed security.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Becton, Dickinson and Company makes medical devices, diagnostics, medication-management systems, specimen-collection products, laboratory instruments and interventional products. Medical technology and healthcare-equipment manufacturing is generally permissible at the activity level, while product use, research and customer applications remain qualitative review topics.
Limitation: The filing does not allocate a universal prohibited-revenue numerator by product, customer use, ingredient or certification; no exact prohibited-revenue percentage is asserted.
Purification
Becton, Dickinson and Company discloses interest income but does not prescribe a scholar-approved purification percentage. Readers should follow the qualified scholar or methodology they use rather than applying an invented fixed rate.
Inputs, assumptions and primary sources
- Inputs use Becton, Dickinson and Company's March 31, 2026 Form 10-Q; amounts are USD millions and revenue and interest income are for the six months ended March 31, 2026.
- Debt uses $2,573 million of current debt obligations plus $14,706 million of long-term debt; restricted cash and operating liabilities are not added separately.
- Cash uses $813 million of cash and equivalents. Short-term investments of $3 million are treated as interest-bearing securities; restricted cash of $202 million is not treated as cash equivalents.
- Receivables use $2,205 million of net trade receivables. Inventories and other current assets are not added.
- Six-month revenue is $9,200 million and disclosed interest income is $13 million. The screen does not infer a fixed purification rate.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →